G Andrew Franz

Title: G Andrew Franz: Innovator in Pharmaceutical Compositions

Introduction

G Andrew Franz is a notable inventor based in St. Louis, MO (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of stable compositions for thyroid hormone drugs. With a total of 3 patents, his work has had a meaningful impact on the medical community.

Latest Patents

Franz's latest patents include innovative methods of administering levothyroxine pharmaceutical compositions. This invention relates to stable pharmaceutical compositions and methods for making and administering such compositions. One aspect of his invention features stabilized pharmaceutical compositions that include active ingredients such as levothyroxine (T4) sodium and liothyronine (T3) sodium, preferably in an immediate release solid dosage form. Additionally, he has developed stabilized pharmaceutical and thyroid hormone compositions that utilize β-sheet microcrystalline cellulose, which improves potency life and methods of preparation.

Career Highlights

Throughout his career, G Andrew Franz has worked with various companies, including Jones Pharma, Inc. His expertise in pharmaceutical compositions has positioned him as a valuable asset in the industry. His innovative approaches have led to advancements in the formulation and administration of thyroid hormone medications.

Collaborations

Franz has collaborated with notable professionals in the field, including Elaine A Strauss and Rocco L Gemma. These collaborations have contributed to the success of his inventions and the advancement of pharmaceutical science.

Conclusion

G Andrew Franz is a distinguished inventor whose work in pharmaceutical compositions has paved the way for improved treatments in thyroid hormone therapy. His patents reflect a commitment to innovation and excellence in the field.